| Source | Code | Name | Case count | Share of cases (%) |
|---|---|---|---|---|
| PURCH | PURCH_ATC(L04AC10) | Secukinumab | 520 | |
| PURCH | PURCH_ATC(L04AC05) | Ustekinumab | 481 | |
| PURCH | PURCH_ATC(L04AC07) | Tocilizumab | 291 | |
| PURCH | PURCH_ATC(L04AC13) | Ixekizumab | 246 | |
| PURCH | PURCH_ATC(L04AC16) | Name not found | 170 | |
| PURCH | PURCH_ATC(L04AC14) | Sarilumab | 100 | |
| PURCH | PURCH_ATC(L04AC18) | Name not found | 62 | |
| PURCH | PURCH_ATC(L04AC03) | Anakinra | 39 | |
| PURCH | PURCH_ATC(L04AC) | Interleukin inhibitors | 27 | |
| PURCH | PURCH_ATC(L04AC12) | Brodalumab | 7 |